(Q52848620)

1 July 2019

title

The contribution of mutant GBA to the development of Parkinson disease in Drosophila. (English)

1 reference

1 July 2019

1 reference

5

0 references

author name string

Gali Maor

1

1 reference

1 July 2019

Or Cabasso

2

1 reference

1 July 2019

Olga Krivoruk

3

1 reference

1 July 2019

Joe Rodriguez

4

1 reference

1 July 2019

Daniel Segal

6

1 reference

1 July 2019

Mia Horowitz

7

1 reference

1 July 2019

publication date

9 May 2016

1 reference

1 July 2019

published in

Human Molecular Genetics

1 reference

1 July 2019

volume

25

1 reference

1 July 2019

issue

13

1 reference

1 July 2019

page(s)

2712-2727

1 reference

1 July 2019

describes a project that uses

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC6390410/fullTextXML

inferred from PubMed Central ID database lookup

cites work

METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Protein quality control, retention, and degradation at the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Glucocerebrosidase processing in normal fibroblasts and in fibroblasts from patients with type I, type II, and type III Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Unfolded protein response in Gaucher disease: from human to Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Occurrence of Parkinson's syndrome in type I Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Gaucher's disease with Parkinson's disease: clinical and pathological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Gaucher disease and parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Gaucher disease and the synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Parkinson's Disease: Genetics and Pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Essential role of the unfolded protein response regulator GRP78/BiP in protection from neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

'Unfolding' pathways in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

An ERcentric view of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Drosophila models of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Drosophila models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Neurophysiology of Drosophila models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Drosophila models of proteinopathies: the little fly that could

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Efficient CRISPR/Cas9 plasmids for rapid and versatile genome editing in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

CRISPR/Cas9 and genome editing in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

GAL4 system in Drosophila: a fly geneticist's Swiss army knife

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Expression of human Gaucher disease gene GBA generates neurodevelopmental defects and ER stress in Drosophila eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Eight different types of dopaminergic neurons innervate the Drosophila mushroom body neuropil: anatomical and physiological heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

A Drosophila model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Chemical and biological approaches synergize to ameliorate protein-folding diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Protein folding and quality control in the ER

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Molecular chaperones as rational drug targets for Parkinson's disease therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Pharmacological chaperones facilitate the post-ER transport of recombinant N370S mutant β-glucocerebrosidase in plant cells: evidence that N370S is a folding mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Overexpression of human glucocerebrosidase containing different-sized leaders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

The Protease Ste24 Clears Clogged Translocons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Endoplasmic reticulum stress-independent activation of unfolded protein response kinases by a small molecule ATP-mimic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Identification and characterization of PERK activators by phenotypic screening and their effects on NRF2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Glucocerebrosidase mutations in subjects with parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Analysis of the glucocerebrosidase gene in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Mutations for Gaucher disease confer high susceptibility to Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Glucocerebrosidase mutations and the pathogenesis of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

No evidence for substrate accumulation in Parkinson brains with GBA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Effective cell and gene therapy in a murine model of Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Mutant GBA1 expression and synucleinopathy risk: first insights from cellular and mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Lessons from Drosophila models of DJ-1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Chaperoning brain degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Lysosomal dysfunction in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

GBA deficiency promotes SNCA/α-synuclein accumulation through autophagic inhibition by inactivated PPP2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

The stress rheostat: an interplay between the unfolded protein response (UPR) and autophagy in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Synucleinopathies from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Aggregation of α-synuclein in brain samples from subjects with glucocerebrosidase mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Association of glucocerebrosidase mutations with dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

A Drosophila model for LRRK2-linked parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDW129

21 January 2018

1 reference

12 December 2020

The cellular response to protein misfolding in the endoplasmic reticulum.

1 reference

12 December 2020

Gaucher disease and parkinsonism: a phenotypic and genotypic characterization

1 reference

12 December 2020

Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage

1 reference

12 December 2020

Gaucher disease associated with parkinsonism: four further case reports

1 reference

12 December 2020

The transposable elements of the Drosophila melanogaster euchromatin: a genomics perspective

1 reference

12 December 2020

A simple method for the isolation and purification of total lipides from animal tissues

1 reference

12 December 2020

ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity

1 reference

12 December 2020

Increased incidence of Parkinson disease among relatives of patients with Gaucher disease

1 reference

12 December 2020

Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset

1 reference

12 December 2020

Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease

1 reference

12 December 2020

The therapeutic potential of chemical chaperones in protein folding diseases.

1 reference

12 December 2020

Role of the unfolded protein response in the pathogenesis of Parkinson's disease

1 reference

12 December 2020

Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cells

1 reference

12 December 2020

Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts

1 reference

12 December 2020

The human glucocerebrosidase gene has two functional ATG initiator codons.

1 reference

12 December 2020

Biosynthesis of the lysosomal enzyme glucocerebrosidase

1 reference

12 December 2020

1 reference

12 December 2020

Gaucher disease: gene frequencies in the Ashkenazi Jewish population

1 reference

12 December 2020

Genetics of Parkinson's disease

1 reference

12 December 2020

Understanding cell death in Parkinson's disease.

1 reference

12 December 2020

Identifiers

DOI

10.1093/HMG/DDW129

1 reference

1 July 2019

PMC publication ID

6390410

1 reference

1 July 2019

PubMed publication ID

27162249

1 reference

1 July 2019